Astrocyte

THE EVOLUTION - CURRENT CONCEPTS IN TUBERCULOSIS
Year
: 2017  |  Volume : 4  |  Issue : 1  |  Page : 27--33

Unveiling the new definitions, diagnostic basis, and therapeutic approaches


Unnati Desai, Jyotsna Joshi 
 Department of Pulmonary Medicine, TNMC and BYL Nair Hospital, Mumbai, Maharashtra, India

Correspondence Address:
Jyotsna Joshi
Department of Pulmonary Medicine, TNMC and BYL Nair Hospital, Mumbai, Maharashtra
India

Tuberculosis (TB) is a notifiable infectious disease. Globally, 20% patients of TB are contributed by India. The World Health Organization (WHO) and the Revised National Tuberculosis Control Program (RNTCP) formulates guidelines for management of TB. There have been advances in various aspects of TB. This review enumerates the progress aiming the therapeutic aspects for TB. The WHO revised definitions in TB in 2013. With the availability of rapid diagnostics and WHO goal of universal access to the same; the diagnostic approach was modified. The RNTCP shifted therapy administration for drug sensitive TB (DS-TB) from thrice weekly to daily regimen in 2017. The WHO updated the drug resistant TB (DR-TB) guidelines in 2016. Bedaquiline and delamanid got enlisted as add-on drugs in the revised classification. In the end, we discuss various pipelines in development of TB.


How to cite this article:
Desai U, Joshi J. Unveiling the new definitions, diagnostic basis, and therapeutic approaches.Astrocyte 2017;4:27-33


How to cite this URL:
Desai U, Joshi J. Unveiling the new definitions, diagnostic basis, and therapeutic approaches. Astrocyte [serial online] 2017 [cited 2022 Jan 28 ];4:27-33
Available from: http://www.astrocyte.in/article.asp?issn=2349-0977;year=2017;volume=4;issue=1;spage=27;epage=33;aulast=Desai;type=0